Modification of mutant K-ras gene expression in non-small cell lung cancer (NSCLC)

Human Gene Therapy

Volumn 7, Issue 7, 1996, Pages 875-889

  Roth, Jack A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; GENE THERAPY; HUMAN; LUNG NON SMALL CELL CANCER; ONCOGENE K RAS; RETROVIRUS;

EID: 0029984307     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.7-875     Document Type: Article

References (17)

1. Brown, C.C. and Kessler, L.G. Projections of lung cancer mortality in the United States: 1985-2025. JNCI, 50:43-51, 1988.
2. Bishop, J.M. Molecular themes in oncogenesis. Cell, 64:235-248, 1991.
3. Shimizu, K., Birnbaum, D., Ruly, M.A., Fasano, O., Suard, Y., Edlund, L., Taparowsky, E., Goldfarb, M., and Wigler, M. Structure of the ki-ras gene of the human lung carcinoma cell line calu-1. Nature, 304:497-500, 1983.
4. Santos, E. and Nebreda, A.R. Structural and functional properties of ras proteins. FASEB, 3:2151-2163, 1989.
5. Rodenhuis, S., Van De Wetering, M.L., Mooi, W.J., Evers, S.G., Van Zandwijk, N., and Bos, J.L. Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung. N Engl J Med, 317 (15):929-935, 1987.
6. Rodenhuis, S., Slebos, R.J.C., Boot, A.J.M., Evers, S.G., Mooi, W.J., Wagenaar, S.S., Van Bodegom, P.C., and Bos, J.L. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res, 45:5738-5741, 1988.
7. Reynolds, S.H., Anna, C.K., Brown, K.C., Wiest, J.S., Beattie, E.J., Pero, R.W., Iglehart, J.D., and Anderson, M.W. Activated protooncogenes in human lung tumors from smokers. Proc Natl Acad Sci USA, 88:1085-1089, 1991.
8. Mukhopadhyay, T., Tainsky, M., Cavender, A.C., and Roth, J.A. Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA. Cancer Res, 51:1744-1748, 1991.
9. Soriano, P., Montgomery, C., Geske, R., and Bradley, A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell, 64:693-702, 1991.
10. Humphrey, E.W., Smart, C.R., Winchester, D.P., Steele, J., Yarbro, J.W., Chu, K.C., and Triolo, H.H. National survey of the pattern of care for carcinoma of the lung. J Thorac Cardiovasc Surg, 100(6):837-843, 1990.
11. Perez, C.A., Stanley, K., Rubin, P., Kramer, S., Brady, L.W., Marks, J.E., Perez-Tamayo, R., Brown, G.S., Concammon, J.P., Rotman, M., and Radiation Therapy Oncology Group. Patterns of tumor recurrence after definitive irradiation for inoperable non-oat cell carcinoma of the lung. Int J. Radiat Oncol Biol Phys, 6:987-994, 1980.
12. Komaki, R., Garden, A.S., and Cundiff, J.H. Endobronchial Radiotherapy. In: J.A. Roth, W.K. Hong and J.D. Cox (eds.), Advances in Lung Cancer. Cambridge, MA: Blackwell Scientific Publications, 1992.
13. Debus, N., Berdichevsky, F.B., and Gryasnov, S.M. Effects of antisense oligodeoxyribonucleotides complementary mRNA of the human c-Harvey-ras oncogene on cell proliferation. J Cancer Res Clin Oncol, 116(Suppl., Part 1): S-1621990.
14. Miller, A.D. and Rosman, G.J. Improved retroviral vectors for gene transfer and expression. Bio Techniques, 7(9):980-990, 1989.
15. Palmer, T.D., Hock, R.A., Osborne, W.R.A., and Miller, A.D. Efficient retrovirus-mediated transfer and expression of a human adenosine deaminase gene in diplid skin fibroblasts from an adenosine deaminase-deficient human. Proc Natl Acad Sci USA, 84: 1055-1059, 1987.
16. Markowitz, D., Goff, S., and Bank, A. Construction and use of a safe and efficient amphotropic packaging cell line. Virol, 167: 400-406, 1988.
17. Rosenberg, S.A., Kasid, A., Anderson, W.F., Blaese, R.M., Aebersold, P., Yang, J., and Topalian, S. Human Gene Ther, 1: 443-462, 1990.